Prof. Nathan Fowler | ICML 2017 | Long-term follow-up of lenalidomide + rituximab in iNHL
Prof. Nathan Fowler, from The University of Texas MD Anderson Cancer Center, on long-term follow-up of lenalidomide + rituximab in iNHL
ICML 2017 | Molecular classification, outcomes, and treatment – Primary Mediastinal B-Cell Lymphoma Session
A session focused on Primary Mediastinal B-Cell Lymphoma (PMBCL) was held during 14-ICML in Lugano, Switzerland, and discussed molecular...
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox every month